Healthcare - Biotechnology - NASDAQ - IT
$ 5.02
1.01 %
$ 91.8 M
Market Cap
-9.84
P/E
BALANCE SHEET
22.3 M
ASSETS
1.91 M
LIABILITIES
20.4 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Genenta Science S.p.A.
| Current Assets | 21.3 M |
| Cash & Short-Term Investments | 18.8 M |
| Receivables | 0 |
| Other Current Assets | 2.48 M |
| Non-Current Assets | 1.09 M |
| Long-Term Investments | 798 K |
| PP&E | 22.4 K |
| Other Non-Current Assets | 271 K |
| Current Liabilities | 1.74 M |
| Accounts Payable | 466 K |
| Short-Term Debt | 0 |
| Other Current Liabilities | 1.27 M |
| Non-Current Liabilities | 179 K |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 179 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 3.7 | 29.8 | 37.2 | 15.5 | 20.1 |
| Short Term Investments | 15.1 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0.1 | 76.3 K | 27.7 K | (0.2) |
| Other Current Assets | 2.5 | 1.9 | 1.5 | 1.1 | 28.5 K |
| Total Current Assets | 21.3 | 31.7 | 38.8 | 16.5 | 20.6 |
| PP&E | 22.4 K | 0.1 | 23.1 K | 19 K | 0 |
| Intangible Assets | 87.8 K | 87.8 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0.8 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.2 | 1.6 | 1.2 | 0.9 | 0.7 |
| Other Assets | 899 | 0 | 0 | 0 | 0 |
| Total Assets | 22.3 | 33.4 | 40.0 | 17.5 | 21.3 |
| LIABILITIES | |||||
| Accounts Payable | 0.5 | 1.2 | 0.2 | 0.6 | 0.6 |
| Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.3 | 1.0 | 0.9 | 1.8 | 1.9 |
| Total Current Liabilities | 1.7 | 2.2 | 1.1 | 2.3 | 2.5 |
| Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.2 | 0.1 | 30.6 K | 17.4 K | 11.3 K |
| Total Liabilities | 1.9 | 2.3 | 1.2 | 2.4 | 2.5 |
| EQUITY | |||||
| Common Stock | 67.3 | 66.6 | 65.9 | 37.1 K | 36 K |
| Retained Earnings | (47.1) | (35.5) | (27.0) | (21.5) | (15.9) |
| Other Accumulative Comprehensive Income/Loss | 0.2 | 0 | 0 | 0 | 0 |
| Total Equity | 20.4 | 31.1 | 38.9 | 15.2 | 18.9 |
| Total Liabilities and Equity | 22.3 | 33.4 | 40.0 | 17.5 | 21.3 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 18.2 | 18.2 | 18.2 | 18.1 | 18.1 |